Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells

被引:27
作者
Cai, Zhigang [1 ,2 ]
Aguilera, Fabiola [1 ]
Ramdas, Baskar [1 ]
Daulatabad, Swapna Vidhur [3 ]
Srivastava, Rajneesh [3 ]
Kotzin, Jonathan J. [4 ]
Carroll, Martin [4 ]
Wertheim, Gerald [4 ]
Williams, Adam [5 ]
Janga, Sarath Chandra [3 ]
Zhang, Chi [6 ]
Henao-Mejia, Jorge [4 ,7 ,8 ]
Kapur, Reuben [1 ,2 ]
机构
[1] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[3] Indiana Univ Purdue Univ, Sch Informat & Comp, Indianapolis, IN 46202 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA
[5] Jackson Lab Genom Med, Farmington, CT USA
[6] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[7] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA
[8] Childrens Hosp Philadelphia, Div Protect Immun, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
HEMATOPOIETIC STEM-CELL; TET2; CANCER; LEADS; FLT3;
D O I
10.1016/j.celrep.2020.107816
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inhibition of anti-apoptotic proteins BCL-2 and MCL-1 to release pro-apoptotic protein BIM and reactivate cell death could potentially be an efficient strategy for the treatment of leukemia. Here, we show that a lncRNA, MORRBID, a selective transcriptional repressor of BIM, is overexpressed in human acute myeloid leukemia (AML), which is associated with poor overall survival. In both human and animal models, MORRBID hyperactivation correlates with two recurrent AML drivers, TET2 and FLT3(ITD). Mice with individual mutations of Tet2 or Flt3(ITD) develop features of chronic myelomonocytic leukemia (CMML) and myeloproliferative neoplasm (MPN), respectively, and combined presence results in AML. We observe increased levels of Morrbid in murine models of CMML, MPN, and AML. Functionally, loss of Morrbid in these models induces increased expression of Bim and cell death in immature and mature myeloid cells, which results in reduced infiltration of leukemic cells in tissues and prolongs the survival of AML mice.
引用
收藏
页数:15
相关论文
共 26 条
[1]   Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice [J].
Anstee, Natasha S. ;
Bilardi, Rebecca A. ;
Ng, Ashley P. ;
Xu, Zhen ;
Robati, Mikara ;
Vandenberg, Cassandra J. ;
Cory, Suzanne .
CELL DEATH AND DIFFERENTIATION, 2019, 26 (07) :1316-1331
[2]   From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors [J].
Ashkenazi, Avi ;
Fairbrother, Wayne J. ;
Leverson, Joel D. ;
Souers, Andrew J. .
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (04) :273-284
[3]   AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies [J].
Caenepeel, Sean ;
Brown, Sean P. ;
Belmontes, Brian ;
Moody, Gordon ;
Keegan, Kathleen S. ;
Chui, Danny ;
Whittington, Douglas A. ;
Huang, Xin ;
Poppe, Leszek ;
Cheng, Alan C. ;
Cardozom, Mario ;
Houze, Jonathan ;
Li, Yunxiao ;
Lucas, Brian ;
Paras, Nick A. ;
Wang, Xianghong ;
Taygerly, Joshua P. ;
Vimolratana, Marc ;
Zancanella, Manuel ;
Zhu, Liusheng ;
Cajulis, Elaina ;
Osgood, Tao ;
Sun, Jan ;
Damon, Leah ;
Egan, Regina K. ;
Greninger, Patricia ;
McClanaghan, Joseph D. ;
Gong, Jianan ;
Moujalled, Donia ;
Pomilio, Giovanna ;
Beltran, Pedro ;
Benes, Cyril H. ;
Roberts, Andrew W. ;
Huang, David C. ;
Wei, Andrew ;
Canon, Jude ;
Coxon, Angela ;
Hughes, Paul E. .
CANCER DISCOVERY, 2018, 8 (12) :1582-1597
[4]   Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis [J].
Cai, Zhigang ;
Kotzin, Jonathan J. ;
Ramdas, Baskar ;
Chen, Sisi ;
Nelanuthala, Sai ;
Palam, Lakshmi Reddy ;
Pandey, Ruchi ;
Mali, Raghuveer Singh ;
Liu, Yan ;
Kelley, Mark R. ;
Sandusky, George ;
Mohseni, Morvarid ;
Williams, Adam ;
Henao-Mejia, Jorge ;
Kapur, Reuben .
CELL STEM CELL, 2018, 23 (06) :833-+
[5]   FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm [J].
Chu, S. Haihua ;
Heiser, Diane ;
Li, Li ;
Kaplan, Ian ;
Collector, Michael ;
Huso, David ;
Sharkis, Saul J. ;
Civin, Curt ;
Small, Don .
CELL STEM CELL, 2012, 11 (03) :346-358
[6]   Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Pratz, Keith ;
Pullarkat, Vinod ;
Jonas, Brian A. ;
Arellano, Martha ;
Becker, Pamela S. ;
Frankfurt, Olga ;
Konopleva, Marina ;
Wei, Andrew H. ;
Kantarjian, Hagop M. ;
Xu, Tu ;
Hong, Wan-Jen ;
Chyla, Brenda ;
Potluri, Jalaja ;
Pollyea, Daniel A. ;
Letai, Anthony .
BLOOD, 2019, 133 (01) :7-17
[7]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[8]   BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis [J].
Huang, Kai ;
O'Neill, Katelyn L. ;
Li, Jian ;
Zhou, Wei ;
Han, Na ;
Pang, Xiaming ;
Wu, Wei ;
Struble, Lucas ;
Borgstahl, Gloria ;
Liu, Zhaorui ;
Zhang, Liqiang ;
Luo, Xu .
CELL RESEARCH, 2019, 29 (11) :942-952
[9]   Clonal hematopoiesis in human aging and disease [J].
Jaiswal, Siddhartha ;
Ebert, Benjamin L. .
SCIENCE, 2019, 366 (6465) :586-+
[10]   Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival [J].
Kikushige, Yoshikane ;
Yoshimoto, Goichi ;
Miyamoto, Toshihiro ;
Iino, Tadafumi ;
Mori, Yasuo ;
Iwasaki, Hirorni ;
Niiro, Hiroaki ;
Takenaka, Katsuto ;
Nagafuji, Koji ;
Harada, Mine ;
Ishikawa, Fumihiko ;
Akashi, Koichi .
JOURNAL OF IMMUNOLOGY, 2008, 180 (11) :7358-7367